Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Scherr, R. Graf, M. Bain, M. Christ-Crain, B. Müller, F. Lajaunias, M. Tamm, D. Stolz (Basel, Zurich, Geneva, Switzerland). Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD. Eur Respir J 2012; 40: Suppl. 56, 1739

Member's Comments

No comment yet.

Related content which might interest you: Pancreatic stone protein is increased in acute exacerbations of COPD with positive sputum bacteriology Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Sputum biomarkers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Effect of sputum bacteriology on the prognosis of patients with acute exacerbations of bronchiectasis Source: International Congress 2017 – COPD and weaning Year: 2017 Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003 The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002 Prediction of imminent COPD exacerbations by sputum analysis Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003 Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004 Bacterial flora in sputum and relationship with lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012 Sputum bacteriology in acute COPD exacerbations: correlation with FEV1 deterioration Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001 Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001 The BAL in the bacteriologic etiology in the COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005 The relation of sputum color to bacterial load in exacerbations of COPD Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Common and atypical pathogens in severe COPD exacerbations and predictors of positive sputum cultures Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Is induced sputum more useful than expectorated sputum to identify respiratory pathogens in children with cystic fibrosis? Source: Eur Respir J 2007; 30: Suppl. 51, 31s Year: 2007 Changes in the induced sputum proteome during COPD exacerbations Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Sputum color as a marker for bacterial infection in severe acute exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 240s Year: 2004 Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD Source: Eur Respir J 2013; 41: 248 Year: 2013 Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD Source: Eur Respir J 2013; 41: 248-249 Year: 2013 Induced sputum concentrations of mucin in patients with asthma and chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 61s Year: 2007